Literature DB >> 10676731

Mouse to elephant: biological scaling and Kt/V.

M A Singer1, A R Morton.   

Abstract

The construct Kt/V is used by the nephrology community in prescribing dialysis dose. The concerns that have been raised as to what value of V to use in the calculation of Kt/V touch on the more central question of whether filtration rate should be normalized by a parameter other than V. Within the animal kingdom, a number of physiological variables scale to body size according to an equation of the form Y = YoMb, where Yo is a constant, M is body mass, and b is a scaling exponent. Glomerular filtration rate (GFR) in mammals weighing from 30 g to 503 kg scales to body weight with an exponent of 0.77. Hence, GFR per unit body weight (or Kt/V) decreases significantly with increasing body size. Metabolic rate also scales to body size in a wide range of mammals according to the same general equation and with a scaling exponent of 0.75. Because GFR and metabolic rate scale to body mass with virtually the same exponent, a ratio of the two yields a constant independent of body size. We propose that the ratio (filtration rate/metabolic rate) replace Kt/V. Such a ratio would underscore the linkage between filtration rate (and dialysis therapy) and the metabolic demands of the body.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10676731     DOI: 10.1016/s0272-6386(00)70341-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  Allometric scaling of xenobiotic clearance: uncertainty versus universality.

Authors:  T M Hu; W L Hayton
Journal:  AAPS PharmSci       Date:  2001

2.  Dialysis cannot be dosed.

Authors:  Timothy W Meyer; Tammy L Sirich; Thomas H Hostetter
Journal:  Semin Dial       Date:  2011-09-19       Impact factor: 3.455

3.  Early B Cell Factor 1 (EBF1) Regulates Glomerular Development by Controlling Mesangial Maturation and Consequently COX-2 Expression.

Authors:  Tracy Nelson; Heino Velazquez; Nancy Troiano; Jackie A Fretz
Journal:  J Am Soc Nephrol       Date:  2019-08-12       Impact factor: 10.121

Review 4.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

5.  Human renal function maturation: a quantitative description using weight and postmenstrual age.

Authors:  Malin M Rhodin; Brian J Anderson; A Michael Peters; Malcolm G Coulthard; Barry Wilkins; Michael Cole; Etienne Chatelut; Anders Grubb; Gareth J Veal; Michael J Keir; Nick H G Holford
Journal:  Pediatr Nephrol       Date:  2008-10-10       Impact factor: 3.714

6.  Association of Alternative Approaches to Normalizing Peritoneal Dialysis Clearance with Mortality and Technique Failure: A Retrospective Analysis Using the United States Renal Data System-Dialysis Morbidity and Mortality Study, Wave 2.

Authors:  Suzanne M Boyle; Yimei Li; F Perry Wilson; Joel D Glickman; Harold I Feldman
Journal:  Perit Dial Int       Date:  2016-09-28       Impact factor: 1.756

Review 7.  Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area.

Authors:  John T Daugirdas; Nathan W Levin; Peter Kotanko; Thomas A Depner; Martin K Kuhlmann; Glenn M Chertow; Michael V Rocco
Journal:  Semin Dial       Date:  2008 Sep-Oct       Impact factor: 3.455

Review 8.  Why Is the GFR So High?: Implications for the Treatment of Kidney Failure.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2020-12-10       Impact factor: 10.614

9.  Early B-cell factor 1 is an essential transcription factor for postnatal glomerular maturation.

Authors:  Jackie A Fretz; Tracy Nelson; Heino Velazquez; Yougen Xi; Gilbert W Moeckel; Mark C Horowitz
Journal:  Kidney Int       Date:  2013-10-30       Impact factor: 10.612

10.  Indexing dialysis dose for gender, body size and physical activity: Impact on survival.

Authors:  Sivakumar Sridharan; Enric Vilar; Andrew Davenport; Neil Ashman; Michael Almond; Anindya Banerjee; Justin Roberts; Ken Farrington
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.